查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768709

全球介入性腫瘤器材市場

Interventional Oncology Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 282 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球介入性腫瘤器材市場規模將達到 39 億美元

全球介入性腫瘤器械市場規模預計在2024年為27億美元，到2030年將達到39億美元，在分析期內（2024-2030年）的複合年成長率為6.4%。栓塞器械是本報告分析的細分市場之一，預計其複合年成長率為7.3%，到分析期結束時規模將達到24億美元。消融器械細分市場在分析期間內的複合年成長率預計為5.3%。

美國市場規模估計為 7.041 億美元，中國市場預計複合年成長率為 9.6%

美國介入性腫瘤器械市場規模預計2024年達到7.041億美元。作為世界第二大經濟體，中國預計在2024-2030年的分析期間內實現9.6%的複合年成長率，到2030年市場規模將達到9.156億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為3.4%和5.7%。在歐洲，預計德國的複合年成長率為3.9%。

全球介入性腫瘤設備市場－主要趨勢與促進因素摘要

介入性腫瘤設備如何推動癌症治療？

介入性腫瘤器械正在徹底改變癌症治療，它透過提供微創手術來精準靶向腫瘤，同時減少對傳統手術的需求並最大限度地減少對周圍組織的損傷。這些器械用於影像導引手術，例如射頻消融 (RFA)、微波消融 (MWA) 和經動脈化療栓塞 (TACE)，將標靶治療直接遞送至腫瘤。介入性腫瘤治療擴大應用於肝癌、肺癌、腎癌和骨癌，為患者提供了一種比開放性手術更安全、創傷更小的治療方法治療方法。這些技術正在提高存活率並縮短復原時間，為不適合傳統手術的患者帶來新的希望。

哪些技術創新正在推動介入腫瘤學的發展？

顯像模式、機器人技術和消融技術的進步正在推動介入腫瘤學的發展。包括核磁共振成像 (MRI)、電腦斷層掃描 (CT) 和超音波在內的影像技術的創新，使得在治療過程中能夠即時、高解析度地可視化腫瘤，從而提高治療的精準度和安全性。機器人系統正在提高介入的精準度，從而能夠更好地瞄準難以觸及部位的腫瘤。新的消融技術，包括微波消融和冷凍消融，正在提供更有效的腫瘤摧毀方法，同時最大限度地減少對健康組織的傷害。這些進步正在擴展介入腫瘤學的能力，使其能夠治療更廣泛的癌症。

市場區隔將如何定義介入性腫瘤設備的成長？

器械類型包括消融器械、栓塞器械和支持器械，其中消融器械佔據市場主導地位，因其廣泛用於微創腫瘤破壞。相關手術包括射頻消融、微波消融和經動脈化療栓塞，其中微波消融因其在治療較大腫瘤方面的高效性而日益普及。介入性腫瘤器械治療的癌症類型包括肝癌、肺癌、腎癌和骨癌，其中肝癌是最大的治療領域，因為肝細胞癌的發生率較高。由於先進的醫療基礎設施和微創治療的日益普及，北美和歐洲等地區的微創治療市場正在顯著成長。

哪些因素推動了介入性腫瘤設備市場的成長？

介入性腫瘤器械市場的成長受到多種因素的推動，例如癌症發病率的上升、人們對微創治療的日益偏好以及影像和消融技術的進步。隨著全球癌症發生率的上升，對更多微創和標靶治療方案的需求也日益成長。介入性腫瘤學透過提供對患者創傷更小、可更快康復的治療方案，提供了一種解決方案。即時成像和精準消融領域的技術創新，透過提高這些治療的有效性和安全性，進一步推動了市場的成長。此外，由於醫療基礎設施的改善和先進醫療技術的普及，新興市場對介入性腫瘤學的採用日益增多，也促進了市場的擴張。

部分

設備（栓塞設備、消融設備、支援設備）、癌症類型（肝癌、乳癌、肺癌、腎癌、攝護腺癌、其他癌症類型）

受訪公司範例

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • CR Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS SA
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP22106

Global Interventional Oncology Devices Market to Reach US$3.9 Billion by 2030

The global market for Interventional Oncology Devices estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Ablation Devices segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$704.1 Million While China is Forecast to Grow at 9.6% CAGR

The Interventional Oncology Devices market in the U.S. is estimated at US$704.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$915.6 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Interventional Oncology Devices Market - Key Trends and Drivers Summarized

How Are Interventional Oncology Devices Advancing Cancer Treatment?

Interventional oncology devices are revolutionizing cancer treatment by offering minimally invasive procedures that target tumors with precision, reducing the need for traditional surgery and minimizing damage to surrounding tissues. These devices are used in image-guided procedures such as radiofrequency ablation (RFA), microwave ablation (MWA), and transarterial chemoembolization (TACE), which deliver targeted therapies directly to tumors. Interventional oncology treatments are increasingly being adopted for liver, lung, kidney, and bone cancers, providing patients with safer, less invasive alternatives to open surgery. These technologies are improving survival rates, reducing recovery times, and offering new hope to patients who may not be candidates for traditional surgery.

What Technological Innovations Are Driving Interventional Oncology?

Technological advancements in imaging modalities, robotics, and ablation techniques are driving the growth of interventional oncology. Innovations in imaging technologies, such as MRI, CT, and ultrasound, are enabling real-time, high-resolution visualization of tumors during procedures, improving the accuracy and safety of treatments. Robotic systems are enhancing the precision of interventions, allowing for better targeting of tumors in hard-to-reach areas. New ablation techniques, including microwave ablation and cryoablation, are providing more effective options for tumor destruction while minimizing damage to healthy tissues. These advancements are expanding the capabilities of interventional oncology and allowing for the treatment of a broader range of cancers.

How Do Market Segments Define the Growth of Interventional Oncology Devices?

Device types include ablation devices, embolization devices, and support devices, with ablation devices leading the market due to their widespread use in minimally invasive tumor destruction. Procedures include radiofrequency ablation, microwave ablation, and transarterial chemoembolization, with microwave ablation gaining popularity due to its higher efficacy in treating larger tumors. Cancer types treated with interventional oncology devices include liver, lung, kidney, and bone cancers, with liver cancer being the largest segment due to the high prevalence of hepatocellular carcinoma. The market is growing significantly in regions such as North America and Europe, driven by the availability of advanced healthcare infrastructure and the increasing adoption of minimally invasive treatments.

What Factors Are Driving the Growth in the Interventional Oncology Devices Market?

The growth in the interventional oncology devices market is driven by several factors, including the increasing incidence of cancer, the growing preference for minimally invasive treatments, and advancements in imaging and ablation technologies. As cancer rates rise globally, demand for less invasive and more targeted treatment options is increasing. Interventional oncology offers a solution by providing procedures that are less traumatic for patients and offer faster recovery times. Technological innovations in real-time imaging and precision ablation are further driving market growth by improving the effectiveness and safety of these treatments. Additionally, the rising adoption of interventional oncology in emerging markets, driven by improving healthcare infrastructure and access to advanced medical technologies, is contributing to the expansion of the market.

SCOPE OF STUDY:

The report analyzes the Interventional Oncology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Embolization Devices, Ablation Devices, Support Devices); Cancer Type (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer, Other Cancer Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • EDAP TMS S.A.
  • Healthtronics, Inc.
  • IMBiotechnologies Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Neuwave Medical, Inc.
  • Profound Medical Corp.
  • Sirtex Medical Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Trod Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Interventional Oncology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Propels Growth in the Interventional Oncology Devices Market
    • Technological Advancements in Image-Guided Cancer Treatment Strengthen Demand for Interventional Devices
    • Growing Use of Minimally Invasive Procedures Fuels Adoption of Interventional Oncology Devices
    • Expansion of Radiofrequency Ablation and Cryoablation Techniques Drives Market Growth
    • Rising Focus on Targeted Cancer Therapies Expands Addressable Market for Interventional Devices
    • Technological Innovations in Microwave Ablation and Embolization Techniques Propel Market Growth
    • Increasing Adoption of Interventional Oncology in Liver, Lung, and Kidney Cancer Treatment Strengthens Market
    • Focus on Reducing Patient Recovery Time and Treatment Side Effects Fuels Demand for Minimally Invasive Solutions
    • Rising Demand for Image-Guided and Navigation-Assisted Cancer Therapies Expands Market Potential
    • Technological Advancements in Catheter-Based Delivery Systems Propel Growth in Interventional Oncology Devices
    • Increasing Focus on Palliative Care and Symptom Management in Cancer Patients Expands Market Opportunities
    • Rising Awareness of Early Cancer Detection and Treatment Options Strengthens Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Lung cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Liver Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Liver Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Kidney Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Kidney Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Interventional Oncology Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Interventional Oncology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ablation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ablation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Interventional Oncology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Interventional Oncology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • INDIA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Interventional Oncology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Interventional Oncology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Interventional Oncology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030
  • AFRICA
    • Interventional Oncology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Interventional Oncology Devices by Cancer Type - Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Interventional Oncology Devices by Cancer Type - Percentage Breakdown of Value Sales for Liver Cancer, Breast Cancer, Lung cancer, Kidney Cancer, Prostate Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Interventional Oncology Devices by Device - Embolization Devices, Ablation Devices and Support Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Interventional Oncology Devices by Device - Percentage Breakdown of Value Sales for Embolization Devices, Ablation Devices and Support Devices for the Years 2015, 2025 & 2030

IV. COMPETITION